biotech

Caris Life Sciences and ConcertAI Announce New Clinico-Genomic Research Platform

by | Jun 1, 2023
Expanding a collaboration they announced in January, the two companies aim to drive "the future of cancer care" with the new platform, enabling novel insights for precision medicine, therapeutic development, and clinical trials management for academic and biopharma researchers.
MORE
Dallas-Based NexPoint Expands Life Sciences Real Estate Footprint with Lab, Distribution Properties
by | May 18, 2023
The multi-billion investment firm’s two-property industrial deal in Philadelphia builds on its commitment to grow in the “critical sector.” Closer to home, NexPoint recently unveiled plans for a massive life sciences district in Plano. The proposed 200-acre TxS development would be a "major economic catalyst" for North Texas, the firm’s founder said in February.
MORE
Busting the Brain’s Firewall: How Lantern Pharma’s Algorithms Can Predict a Drug’s Ability to Reach the Brain
by | May 2, 2023
The "blood-brain barrier" acts like a highly selective firewall, preventing an estimated 98% of drugs from entering the brain—making it a major hurdle in the development of brain and central nervous system drugs. Lantern Pharma has recently developed what it calls "highly accurate AI algorithms" to predict the ability of a drug or compound to pass through the barrier.
MORE
16 Biotech Companies in Dallas-Fort Worth ‘Putting the Tech in Bio’ to Drive Breakthroughs

Dallas-Fort Worth is well known for its tech expertise. Now it being recognized as the place where technology meets life science—a convergence that’s driving rapid growth in the biotech ecosystem....

MORE

Emerging Trends: Three Futurists Predict The Tech That Comes Next

by | Feb 15, 2023
From AI to human longevity to xTech, North Texas experts George Brody of InfoNet of Things and Anurag Jain of Perot Jain, along with Mike Bechtel of Deloitte, predict a range of emerging technologies set to transform the world in 2023 and beyond.
MORE
Nanoscope Therapeutics Names New Vice President of Quality
by | Jan 11, 2023

Nanoscope Therapeutics Inc., a Dallas-based clinical-stage biotechnology company developing gene therapies for retinal degenerative diseases, has appointed Massoud Motamed, Ph.D., as vice president of quality.

Motamed brings nearly a decade of CGMP quality and compliance experience, including extensive experience in manufacturing and regulatory review of gene therapy products....

MORE
NanOlogy Sees ‘Encouraging Signs’ for Its Microparticle Drug Delivery in Nonoperable Lung Cancer Patients
by | Nov 20, 2022

Fort Worth-based NanOlogy has completed the enrollment of 18 patients in a Phase 2a trial for its proprietary particle drug delivery with standard-of care therapy in nonoperable lung cancer patients....

MORE

Form Bio Spins Out of Colossal Bioscience to Offer Scientists the ‘Missing Piece’

by | Sep 27, 2022
Dallas-based Colossal Biosciences, the de-extinction company behind plans to bring back the woolly mammoth and thylacine, developed its own software solution "after reviewing everything available on the market." Now it's sharing the platform with the launch of Form Bio.

The spinout's technology tools can help drive the “entire molecular revolution” that is occurring in the life sciences and biotech space, in addition to bolstering the Lone Star state as a hub for the industry, says Chief Strategy Officer Claire Aldridge.
MORE
Runway Growth Capital Adds to Life Science Team With New Dallas Managing Director
by | Aug 20, 2022
Brannon Morisoli will join the team at a time when life science is booming in North Texas. Most recently, Dallas-Fort Worth ranked for the first time in the "Top 20 U.S. metros for life science" 2022 report by CommercialEdge. 
MORE
Fueling the Biotech Boom: Dallas College Lands ‘Historic’ $8.8M Grant to Train Workers as North Texas’ Life Sciences Sector Soars
by | Aug 3, 2022
Top North Texas healthcare and life science employers—including UT Southwestern, McKesson, Evolve Biologics, Texas Health Resources, and more—have already signed up to hire 1,100 biotech workers from the groundbreaking program.

27,000 workers have made Dallas-Fort Worth a Top 20 U.S. metro for life sciences companies. As the boom continues, they’ll need company. Here's how the grant will help Dallas College and other local higher ed institutions step up to provide it—and why a CEO at Lyda Hill Philantrhopies calls it a "game changer."
MORE
At the Fourth Annual iC3 Life Science Summit at UT Arlington on Oct. 10, 2017 recipient Lyda Hill will present the award. To register for the summit, visit www.bionorthtx.org. [Illustration: bestbrk/istockphoto]
Dallas-Fort Worth Makes List of Top 20 Life Science Metros
by | Jul 8, 2022
See how the region ranked.
MORE
From right: DRC's Jorge Varela (far right) moderated a panel of industry experts including biotech C-level executive Hua Tu, Health Wildcatters CEO and co-founder Hubert Zajicek, and LH Capital Director Matt Crommett.

‘From a Trickle to a Waterfall’: How Biotech’s Flow is Growing in DFW

by | May 24, 2022
"It takes time" to establish a track record, Jorge Varela says, and the region is starting to see a series of biotech successes and spinoffs that will elevate the region's profile as a biotech hub.

According to a panel of experts at Urban Land Institute's 2022 spring meeting, here are factors drawing biotech to DFW.
MORE
Southwestern Medical Foundation President and CEO Kathleen Gibson has joined the board of nonprofit LaunchBio. [Image: Southwestern Medical Foundation; istockphoto]
Southwestern Medical Foundation President and CEO Joins LaunchBio Board
by | Apr 29, 2022
LaunchBio, a life science and biotech nonprofit that expanded to North Texas in 2021, has announced four new board members, including Dallas-based Kathleen Gibson, along with a new board chair.

LaunchBio is working to accelerate the entrepreneurial support network in the region through collaborations with BioLabs, Lyda Hill Philanthropies, J. Small Investments, BioNTX, DLA Piper, and others.
MORE
TCU School of Medicine Is Building a New Campus in Fort Worth’s Medical District
by | Mar 1, 2022
The project will kick off with a four-story, approximately 100,000-square-foot medical education building, which TCU says will serve as an “academic hub” for around 240 students and hundreds of faculty and staff members, after its planned completion in 2024. At the new campus, TCU School of Medicine's innovative curriculum will continue—with students focused on major drivers of medicine's future, including AI, genomics, and advanced monitoring technology.
MORE
Protecting your privacy. We have strengthened our Privacy Policy to better protect you. This Policy includes our use of cookies to give you the best online experience and provide functionality essential to our services. By clicking ‘I Accept’ or by continuing to use our website, you are consenting to our Privacy Policy.